一个横截面的比较研究
Mihaela Paula Toader1, Oana Mihaela Condurache Hrițcu1, Cristina Colac Boțoc2
1Discipline of Oral Medicine, Oral Dermatology, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, 700115 Iasi, Romania.
Diagnostics (Basel, Switzerland)
|August 28, 2025
概括
与对照组相比,平患者患高血压和2型糖尿病的风险更高. 口腔平菌亚型表现出明显的代谢特征,这表明需要在LP患者中进行代谢查.
科学领域:
- 皮肤病学
- 心脏病学
- 内分泌学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因.
- 牛皮是心脏代谢风险的一个已知因素.
- 平 (LP) 是一种关于心脏代谢风险的慢性炎症疾病.
研究的目的:
- 为了比较LP患者和健康对照者的代谢综合征 (MetS) 成分的患病率和临床模式.
- 评估不接受全身治疗的患者的内在炎症负担.
- 检查特定的LP亚型是否具有不同的代谢特征.
主要方法:
- 一个横截面观察研究包括236名成年患者 (78名LP,79名牛皮,79名对照).
- 收集的数据包括人口统计,临床特征和实验室结果.
- 使用经过验证的指数评估LP亚型和牛皮的严重程度;根据指南评估心脏代谢并发症.
主要成果:
- 与对照组相比,LP患者患高血压 (OR 1.94) 和2型糖尿病 (OR 3.09) 的几率更高.
- 与牛皮相比,LP与较高的混合性脂质失血症 (OR 3.41) 有关.
- 口服LP亚型,特别是侵蚀性和网状形式,与心脏代谢风险增加有关.
结论:
- 平,特别是口腔亚型,具有明显的心脏代谢风险概况,与牛皮相似或超过.
- 这些发现强调了对LP患者进行系统代谢查的重要性.
- 建议综合皮肤和代谢护理用于全面的患者管理.
更多相关视频
相关概念视频
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
57
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
57
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
213
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Rheumatic Heart Disease III: Medical Management
31
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
31


